Stem Cell Therapy Market Likely to Surpass USD 3 Billion by 2035

Global Stem Cell Therapy Market Forecast 2035:

According to the report, the global stem cell therapy market is projected to expand from USD 0.6 billion in 2025 to USD 3 billion by 2035, registering a CAGR of 17.4%, the highest during the forecast period. The rising clinical approvals and commercialization of sophisticated cell therapies drive the stem cell therapy market. For instance, in December 2024, Mesoblast Limited was the first company to win an FDA approval and to commercially launch one of the first commercially available MSC therapies with strong clinical responses, namely, Ryoncil (remestemcel‑L) aimed at treating steroid-refractory acute graft-versus-host disease in children. This regulatory achievement will increase the credibility of the market, increase access to treatment by patients, and promote faster receiving of stem cell treatments worldwide.

Additionally, the growing use of stem cell therapies in chronic and degenerative diseases is also fuelling the growth of the market through the provision of clinical need gaps and widening the treatment modalities. For instance, in December 2025, Cipla and Stempeutics introduce Ciplostem, an allogeneic mesenchymal stem cell-based cure of knee osteoarthritis in India, which fulfills unmet requirements in orthobiologic. These developments are accelerating market acceptance, increasing clinical signs, and improving business pipelines hence sector growth.

“Key Driver, Restraint, and Growth Opportunity Shaping the Global Stem Cell Therapy Market”

The growing need to treat age-related, autoimmune, and inflammatory diseases, osteoarthritis, neurodegenerative disorders, and cardiovascular diseases with stem cell therapies is being driven by the need to treat disease-modifying and regenerative conditions. Traditional treatment methods tend to be symptomatic, and the stem cell-based methods have some potential to repair tissues and restore their functions, which contribute to better long-term clinical events and spur further market expansion.

The development of stem cell therapies is experiencing major issues surrounding cumbersome manufacturing methods, such as sourcing of cells, their expansion, quality control, and cold-chain logistics. The challenge of sustaining consistency, viability and sterility on a commercial scale has made production more expensive and hindered the capacity of manufacturers to produce at the rising global demand with efficiency especially in autologous and personalized therapies.

Performing artificial intelligence and data analytics incorporation into stem cell manufacturing and clinical workflow is an enormous growth opportunity. Scalability, reduced production variability, and increased therapeutic efficacy can be improved using AI-targeted process optimization, predictive quality control, and patient-specific treatment modeling to foster the faster commercialization and increased adoption of stem cell therapies across the globe.

Expansion of Global Stem Cell Therapy Market

“Expansion in Cryopreservation and Biobanking Enabling Long-Term Stem Cell Storage”

The stem cell therapy market is expanding due to the increase of cryopreservation and biobanking service, which is allowing longer term storage, access, and reuse of high-quality stem cells in clinical settings. Improved biobanking infrastructure will guarantee the maintenance of cells, personalized therapy, and mass use of the therapy, thereby enhancing patient outcomes and boosting the swift adoption of the therapy in the market.
For instance, in April 2025, BioLife Solutions Inc. obtained 90% of shares of PanTHERA CryoSolutions Inc. at a price of 21.53 million dollars, increasing its technological base in the field of stem cell cryopreservation and broadening its presence in the sphere of developed biobanking services. The acquisition is enhancing scaleable and superior quality cryopreservation and storage of clinical stem cell therapies.
This increase in cryopreservation and biobanking increases access to therapies across the globe, results in consistency in treatment and hastens the uptake of the stem cell-based clinical uses.

Regional Analysis of Global Stem Cell Therapy Market

North America has dominated the global stem cell therapy market due to the developed healthcare system, significant investments in research on regenerative medicine by both the government and individual stakeholders, and favorable regulatory environment that facilitates clinical trials and approvals of new stem cell therapies. A significant portion of ongoing clinical research and commercialized therapies is also in the U.S., backed by organizations such as FDA and centers such as the California Institute of Regenerative Medicine, which license significant funding measures.
Asia Pacific’s stem cell therapy market is growing rapidly due to increasing healthcare investment, expansion of clinical trials, and emerging biotech hubs in China, Japan, and South Korea, where government support and large patient populations accelerate adoption of regenerative treatments for chronic conditions.

Prominent players operating in the global stem cell therapy market are Anterogen Co., Ltd., Astellas Pharma Inc., Athersys Inc., Brainstorm Cell Therapeutics, Caladrius Biosciences Inc., CBR Systems Inc., Cellular Engineering Technologies Inc., CORESTEM Inc., Cynata Therapeutics Limited, Fate Therapeutics Inc., Holostem Terapie Avanzate S.r.l., JCR Pharmaceuticals Co., Ltd., MEDIPOST Co., Ltd., Mesoblast Ltd, NuVasive Inc., Osiris Therapeutics (Smith & Nephew), Pharmicell Co., Ltd., Pluristem Therapeutics Inc., Stempeutics Research Pvt Ltd, Takeda Pharmaceutical Company Limited, Vericel Corporation, ViaCyte Inc., and Other Key Players.

The global stem cell therapy market has been segmented as follows:

Global Stem Cell Therapy Market Analysis, By Cell Source

Autologous Stem Cells
Allogeneic Stem Cells
Syngeneic Stem Cells

Global Stem Cell Therapy Market Analysis, By Cell Type

Adult Stem Cells
- Hematopoietic Stem Cells
- Mesenchymal Stem Cells
- Neural Stem Cells
- Epithelial Stem Cells
Embryonic Stem Cells
Induced Pluripotent Stem Cells (iPSCs)
Very Small Embryonic-Like Stem Cells

Global Stem Cell Therapy Market Analysis, By Technology

Cell Acquisition
Cell Production
Cryopreservation
Expansion and Sub-culture

Global Stem Cell Therapy Market Analysis, By Therapeutic Application

Musculoskeletal Disorders
- Osteoarthritis
- Rheumatoid Arthritis
- Spinal Cord Injury
Wounds and Injuries
Cardiovascular Diseases
- Myocardial Infarction
- Congestive Heart Failure
Inflammatory and Autoimmune Diseases
- Crohn's Disease
- Multiple Sclerosis
Neurological Disorders
- Parkinson's Disease
- Alzheimer's Disease
- Stroke
Cancer
- Leukemia
- Lymphoma
- Multiple Myeloma
Diabetes
- Type 1 Diabetes
- Type 2 Diabetes
Liver Disorders
Blood Disorders
Others

Global Stem Cell Therapy Market Analysis, By Treatment Approach

Stem Cell Transplantation
Bone Marrow Transplantation
Peripheral Blood Stem Cell Transplantation
Cord Blood Transplantation
Stem Cell Banking
Regenerative Medicine

Global Stem Cell Therapy Market Analysis, By End-Use

Hospitals & Surgical Centers
Specialty Clinics
Research Institutes & Academic Centers
Pharmaceutical & Biotechnology Companies
Cell & Tissue Banks
Ambulatory Surgical Centers
Others

Global Stem Cell Therapy Market Analysis, By Region

North America
Europe
Asia Pacific
Middle East
Africa
South America

About Us

MarketGenics is a global market research and management consulting company empowering decision makers from startups, Fortune 500 companies, non-profit organizations, universities and government institutions. Our main goal is to assist and partner organizations to make lasting strategic improvements and realize growth targets. Our industry research reports are designed to provide granular quantitative information, combined with key industry insights, aimed at assisting sustainable organizational development.

We serve clients on every aspect of strategy, including product development, application modeling, exploring new markets and tapping into niche growth opportunities.

Contact Us

USA Address:

800 N King Street Suite 304 #4208 Wilmington, DE 19801 United States.

+1(302)303-2617

info@marketgenics.co

India Address:

3rd floor, Indeco Equinox, Baner Road, Baner, Pune, Maharashtra 411045 India.

sales@marketgenics.co

Table of Contents

1. Research Methodology and Assumptions
- 1.1. Definitions
- 1.2. Research Design and Approach
- 1.3. Data Collection Methods
- 1.4. Base Estimates and Calculations
- 1.5. Forecasting Models
  - 1.5.1. Key Forecast Factors & Impact Analysis
- 1.6. Secondary Research
  - 1.6.1. Open Sources
  - 1.6.2. Paid Databases
  - 1.6.3. Associations
- 1.7. Primary Research
  - 1.7.1. Primary Sources
  - 1.7.2. Primary Interviews with Stakeholders across Ecosystem
2. Executive Summary
- 2.1. Global Stem Cell Therapy Market Outlook
  - 2.1.1. Stem Cell Therapy Market Size (Value - US$ Bn), and Forecasts, 2021-2035
  - 2.1.2. Compounded Annual Growth Rate Analysis
  - 2.1.3. Growth Opportunity Analysis
  - 2.1.4. Segmental Share Analysis
  - 2.1.5. Geographical Share Analysis
- 2.2. Market Analysis and Facts
- 2.3. Supply-Demand Analysis
- 2.4. Competitive Benchmarking
- 2.5. Go-to- Market Strategy
  - 2.5.1. Customer/ End-use Industry Assessment
  - 2.5.2. Growth Opportunity Data, 2026-2035
    - 2.5.2.1. Regional Data
    - 2.5.2.2. Country Data
    - 2.5.2.3. Segmental Data
  - 2.5.3. Identification of Potential Market Spaces
  - 2.5.4. GAP Analysis
  - 2.5.5. Potential Attractive Price Points
  - 2.5.6. Prevailing Market Risks & Challenges
  - 2.5.7. Preferred Sales & Marketing Strategies
  - 2.5.8. Key Recommendations and Analysis
  - 2.5.9. A Way Forward
3. Industry Data and Premium Insights
- 3.1. Global Healthcare & Pharmaceutical Industry Overview, 2025
  - 3.1.1. Healthcare & Pharmaceutical Ecosystem Analysis
  - 3.1.2. Key Trends for Healthcare & Pharmaceutical Industry
  - 3.1.3. Regional Distribution for Healthcare & Pharmaceutical Industry
- 3.2. Supplier Customer Data
- 3.3. Technology Roadmap and Developments
- 3.4. Trade Analysis
  - 3.4.1. Import & Export Analysis, 2025
  - 3.4.2. Top Importing Countries
  - 3.4.3. Top Exporting Countries
- 3.5. Trump Tariff Impact Analysis
  - 3.5.1. Manufacturer
    - 3.5.1.1. Based on the component & Raw material
  - 3.5.2. Supply Chain
  - 3.5.3. End Consumer
- 3.6. Raw Material Analysis
4. Market Overview
- 4.1. Market Dynamics
  - 4.1.1. Drivers
    - 4.1.1.1. Rising prevalence of chronic and degenerative diseases (e.g., cardiovascular, diabetes, neurological disorders)
    - 4.1.1.2. Advancements in stem cell research and technologies (including iPSCs and 3D bioprinting)
    - 4.1.1.3. Increased clinical trials, regulatory approvals, and supportive government funding
  - 4.1.2. Restraints
    - 4.1.2.1. High cost of treatment and associated clinical processes
    - 4.1.2.2. Regulatory challenges and ethical concerns, especially around embryonic stem cells
- 4.2. Key Trend Analysis
- 4.3. Regulatory Framework
  - 4.3.1. Key Regulations, Norms, and Subsidies, by Key Countries
  - 4.3.2. Tariffs and Standards
  - 4.3.3. Impact Analysis of Regulations on the Market
- 4.4. Value Chain Analysis
  - 4.4.1. Technology & Equipment Suppliers
  - 4.4.2. Raw Material & Consumables Suppliers
  - 4.4.3. Cell Processing and Manufacturing Companies
  - 4.4.4. Clinical Research Organizations and Healthcare Providers
  - 4.4.5. Logistics & Commercialization
- 4.5. Porter’s Five Forces Analysis
- 4.6. PESTEL Analysis
- 4.7. Global Stem Cell Therapy Market Demand
  - 4.7.1. Historical Market Size – Value (US$ Bn), 2020-2024
  - 4.7.2. Current and Future Market Size – Value (US$ Bn), 2026–2035
    - 4.7.2.1. Y-o-Y Growth Trends
    - 4.7.2.2. Absolute $ Opportunity Assessment
5. Competition Landscape
- 5.1. Competition structure
  - 5.1.1. Fragmented v/s consolidated
- 5.2. Company Share Analysis, 2025
  - 5.2.1. Global Company Market Share
  - 5.2.2. By Region
    - 5.2.2.1. North America
    - 5.2.2.2. Europe
    - 5.2.2.3. Asia Pacific
    - 5.2.2.4. Middle East
    - 5.2.2.5. Africa
    - 5.2.2.6. South America
- 5.3. Product Comparison Matrix
  - 5.3.1. Specifications
  - 5.3.2. Market Positioning
  - 5.3.3. Pricing
6. Global Stem Cell Therapy Market Analysis, by Cell Source
- 6.1. Key Segment Analysis
- 6.2. Stem Cell Therapy Market Size (Value - US$ Bn), Analysis, and Forecasts, by Cell Source, 2021-2035
  - 6.2.1. Autologous Stem Cells
  - 6.2.2. Allogeneic Stem Cells
  - 6.2.3. Syngeneic Stem Cells
7. Global Stem Cell Therapy Market Analysis, by Cell Type
- 7.1. Key Segment Analysis
- 7.2. Stem Cell Therapy Market Size (Value - US$ Bn), Analysis, and Forecasts, by Cell Type, 2021-2035
  - 7.2.1. Adult Stem Cells
    - 7.2.1.1. Hematopoietic Stem Cells
    - 7.2.1.2. Mesenchymal Stem Cells
    - 7.2.1.3. Neural Stem Cells
    - 7.2.1.4. Epithelial Stem Cells
  - 7.2.2. Embryonic Stem Cells
  - 7.2.3. Induced Pluripotent Stem Cells (iPSCs)
  - 7.2.4. Very Small Embryonic-Like Stem Cells
8. Global Stem Cell Therapy Market Analysis, by Technology
- 8.1. Key Segment Analysis
- 8.2. Stem Cell Therapy Market Size (Value - US$ Bn), Analysis, and Forecasts, by Technology, 2021-2035
  - 8.2.1. Cell Acquisition
  - 8.2.2. Cell Production
  - 8.2.3. Cryopreservation
  - 8.2.4. Expansion and Sub-culture
9. Global Stem Cell Therapy Market Analysis, by Therapeutic Application
- 9.1. Key Segment Analysis
- 9.2. Stem Cell Therapy Market Size (Value - US$ Bn), Analysis, and Forecasts, by Therapeutic Application, 2021-2035
  - 9.2.1. Musculoskeletal Disorders
    - 9.2.1.1. Osteoarthritis
    - 9.2.1.2. Rheumatoid Arthritis
    - 9.2.1.3. Spinal Cord Injury
  - 9.2.2. Wounds and Injuries
  - 9.2.3. Cardiovascular Diseases
    - 9.2.3.1. Myocardial Infarction
    - 9.2.3.2. Congestive Heart Failure
  - 9.2.4. Inflammatory and Autoimmune Diseases
    - 9.2.4.1. Crohn's Disease
    - 9.2.4.2. Multiple Sclerosis
  - 9.2.5. Neurological Disorders
    - 9.2.5.1. Parkinson's Disease
    - 9.2.5.2. Alzheimer's Disease
    - 9.2.5.3. Stroke
  - 9.2.6. Cancer
    - 9.2.6.1. Leukemia
    - 9.2.6.2. Lymphoma
    - 9.2.6.3. Multiple Myeloma
  - 9.2.7. Diabetes
    - 9.2.7.1. Type 1 Diabetes
    - 9.2.7.2. Type 2 Diabetes
  - 9.2.8. Liver Disorders
  - 9.2.9. Blood Disorders
  - 9.2.10. Others
10. Global Stem Cell Therapy Market Analysis, by Treatment Approach
- 10.1. Key Segment Analysis
- 10.2. Stem Cell Therapy Market Size (Value - US$ Bn), Analysis, and Forecasts, by Treatment Approach, 2021-2035
  - 10.2.1. Stem Cell Transplantation
  - 10.2.2. Bone Marrow Transplantation
  - 10.2.3. Peripheral Blood Stem Cell Transplantation
  - 10.2.4. Cord Blood Transplantation
  - 10.2.5. Stem Cell Banking
  - 10.2.6. Regenerative Medicine
11. Global Stem Cell Therapy Market Analysis, by End-Use
- 11.1. Key Segment Analysis
- 11.2. Stem Cell Therapy Market Size (Value - US$ Bn), Analysis, and Forecasts, by End-Use, 2021-2035
  - 11.2.1. Hospitals & Surgical Centers
  - 11.2.2. Specialty Clinics
  - 11.2.3. Research Institutes & Academic Centers
  - 11.2.4. Pharmaceutical & Biotechnology Companies
  - 11.2.5. Cell & Tissue Banks
  - 11.2.6. Ambulatory Surgical Centers
  - 11.2.7. Others
12. Global Stem Cell Therapy Market Analysis and Forecasts, by Region
- 12.1. Key Findings
- 12.2. Stem Cell Therapy Market Size (Value - US$ Bn), Analysis, and Forecasts, by Region, 2021-2035
  - 12.2.1. North America
  - 12.2.2. Europe
  - 12.2.3. Asia Pacific
  - 12.2.4. Middle East
  - 12.2.5. Africa
  - 12.2.6. South America
13. North America Stem Cell Therapy Market Analysis
- 13.1. Key Segment Analysis
- 13.2. Regional Snapshot
- 13.3. North America Stem Cell Therapy Market Size (Value - US$ Bn), Analysis, and Forecasts, 2021-2035
  - 13.3.1. Cell Source
  - 13.3.2. Cell Type
  - 13.3.3. Technology
  - 13.3.4. Therapeutic Application
  - 13.3.5. Treatment Approach
  - 13.3.6. End-Use
  - 13.3.7. Country
    - 13.3.7.1. USA
    - 13.3.7.2. Canada
    - 13.3.7.3. Mexico
- 13.4. USA Stem Cell Therapy Market
  - 13.4.1. Country Segmental Analysis
  - 13.4.2. Cell Source
  - 13.4.3. Cell Type
  - 13.4.4. Technology
  - 13.4.5. Therapeutic Application
  - 13.4.6. Treatment Approach
  - 13.4.7. End-Use
- 13.5. Canada Stem Cell Therapy Market
  - 13.5.1. Country Segmental Analysis
  - 13.5.2. Cell Source
  - 13.5.3. Cell Type
  - 13.5.4. Technology
  - 13.5.5. Therapeutic Application
  - 13.5.6. Treatment Approach
  - 13.5.7. End-Use
- 13.6. Mexico Stem Cell Therapy Market
  - 13.6.1. Country Segmental Analysis
  - 13.6.2. Cell Source
  - 13.6.3. Cell Type
  - 13.6.4. Technology
  - 13.6.5. Therapeutic Application
  - 13.6.6. Treatment Approach
  - 13.6.7. End-Use
14. Europe Stem Cell Therapy Market Analysis
- 14.1. Key Segment Analysis
- 14.2. Regional Snapshot
- 14.3. Europe Stem Cell Therapy Market Size (Value - US$ Bn), Analysis, and Forecasts, 2021-2035
  - 14.3.1. Cell Source
  - 14.3.2. Cell Type
  - 14.3.3. Technology
  - 14.3.4. Therapeutic Application
  - 14.3.5. Treatment Approach
  - 14.3.6. End-Use
  - 14.3.7. Country
    - 14.3.7.1. Germany
    - 14.3.7.2. United Kingdom
    - 14.3.7.3. France
    - 14.3.7.4. Italy
    - 14.3.7.5. Spain
    - 14.3.7.6. Netherlands
    - 14.3.7.7. Nordic Countries
    - 14.3.7.8. Poland
    - 14.3.7.9. Russia & CIS
    - 14.3.7.10. Rest of Europe
- 14.4. Germany Stem Cell Therapy Market
  - 14.4.1. Country Segmental Analysis
  - 14.4.2. Cell Source
  - 14.4.3. Cell Type
  - 14.4.4. Technology
  - 14.4.5. Therapeutic Application
  - 14.4.6. Treatment Approach
  - 14.4.7. End-Use
- 14.5. United Kingdom Stem Cell Therapy Market
  - 14.5.1. Country Segmental Analysis
  - 14.5.2. Cell Source
  - 14.5.3. Cell Type
  - 14.5.4. Technology
  - 14.5.5. Therapeutic Application
  - 14.5.6. Treatment Approach
  - 14.5.7. End-Use
- 14.6. France Stem Cell Therapy Market
  - 14.6.1. Country Segmental Analysis
  - 14.6.2. Cell Source
  - 14.6.3. Cell Type
  - 14.6.4. Technology
  - 14.6.5. Therapeutic Application
  - 14.6.6. Treatment Approach
  - 14.6.7. End-Use
- 14.7. Italy Stem Cell Therapy Market
  - 14.7.1. Country Segmental Analysis
  - 14.7.2. Cell Source
  - 14.7.3. Cell Type
  - 14.7.4. Technology
  - 14.7.5. Therapeutic Application
  - 14.7.6. Treatment Approach
  - 14.7.7. End-Use
- 14.8. Spain Stem Cell Therapy Market
  - 14.8.1. Country Segmental Analysis
  - 14.8.2. Cell Source
  - 14.8.3. Cell Type
  - 14.8.4. Technology
  - 14.8.5. Therapeutic Application
  - 14.8.6. Treatment Approach
  - 14.8.7. End-Use
- 14.9. Netherlands Stem Cell Therapy Market
  - 14.9.1. Country Segmental Analysis
  - 14.9.2. Cell Source
  - 14.9.3. Cell Type
  - 14.9.4. Technology
  - 14.9.5. Therapeutic Application
  - 14.9.6. Treatment Approach
  - 14.9.7. End-Use
- 14.10. Nordic Countries Stem Cell Therapy Market
  - 14.10.1. Country Segmental Analysis
  - 14.10.2. Cell Source
  - 14.10.3. Cell Type
  - 14.10.4. Technology
  - 14.10.5. Therapeutic Application
  - 14.10.6. Treatment Approach
  - 14.10.7. End-Use
- 14.11. Poland Stem Cell Therapy Market
  - 14.11.1. Country Segmental Analysis
  - 14.11.2. Cell Source
  - 14.11.3. Cell Type
  - 14.11.4. Technology
  - 14.11.5. Therapeutic Application
  - 14.11.6. Treatment Approach
  - 14.11.7. End-Use
- 14.12. Russia & CIS Stem Cell Therapy Market
  - 14.12.1. Country Segmental Analysis
  - 14.12.2. Cell Source
  - 14.12.3. Cell Type
  - 14.12.4. Technology
  - 14.12.5. Therapeutic Application
  - 14.12.6. Treatment Approach
  - 14.12.7. End-Use
- 14.13. Rest of Europe Stem Cell Therapy Market
  - 14.13.1. Country Segmental Analysis
  - 14.13.2. Cell Source
  - 14.13.3. Cell Type
  - 14.13.4. Technology
  - 14.13.5. Therapeutic Application
  - 14.13.6. Treatment Approach
  - 14.13.7. End-Use
15. Asia Pacific Stem Cell Therapy Market Analysis
- 15.1. Key Segment Analysis
- 15.2. Regional Snapshot
- 15.3. Asia Pacific Stem Cell Therapy Market Size (Value - US$ Bn), Analysis, and Forecasts, 2021-2035
  - 15.3.1. Cell Source
  - 15.3.2. Cell Type
  - 15.3.3. Technology
  - 15.3.4. Therapeutic Application
  - 15.3.5. Treatment Approach
  - 15.3.6. End-Use
  - 15.3.7. Country
    - 15.3.7.1. China
    - 15.3.7.2. India
    - 15.3.7.3. Japan
    - 15.3.7.4. South Korea
    - 15.3.7.5. Australia and New Zealand
    - 15.3.7.6. Indonesia
    - 15.3.7.7. Malaysia
    - 15.3.7.8. Thailand
    - 15.3.7.9. Vietnam
    - 15.3.7.10. Rest of Asia Pacific
- 15.4. China Stem Cell Therapy Market
  - 15.4.1. Country Segmental Analysis
  - 15.4.2. Cell Source
  - 15.4.3. Cell Type
  - 15.4.4. Technology
  - 15.4.5. Therapeutic Application
  - 15.4.6. Treatment Approach
  - 15.4.7. End-Use
- 15.5. India Stem Cell Therapy Market
  - 15.5.1. Country Segmental Analysis
  - 15.5.2. Cell Source
  - 15.5.3. Cell Type
  - 15.5.4. Technology
  - 15.5.5. Therapeutic Application
  - 15.5.6. Treatment Approach
  - 15.5.7. End-Use
- 15.6. Japan Stem Cell Therapy Market
  - 15.6.1. Country Segmental Analysis
  - 15.6.2. Cell Source
  - 15.6.3. Cell Type
  - 15.6.4. Technology
  - 15.6.5. Therapeutic Application
  - 15.6.6. Treatment Approach
  - 15.6.7. End-Use
- 15.7. South Korea Stem Cell Therapy Market
  - 15.7.1. Country Segmental Analysis
  - 15.7.2. Cell Source
  - 15.7.3. Cell Type
  - 15.7.4. Technology
  - 15.7.5. Therapeutic Application
  - 15.7.6. Treatment Approach
  - 15.7.7. End-Use
- 15.8. Australia and New Zealand Stem Cell Therapy Market
  - 15.8.1. Country Segmental Analysis
  - 15.8.2. Cell Source
  - 15.8.3. Cell Type
  - 15.8.4. Technology
  - 15.8.5. Therapeutic Application
  - 15.8.6. Treatment Approach
  - 15.8.7. End-Use
- 15.9. Indonesia Stem Cell Therapy Market
  - 15.9.1. Country Segmental Analysis
  - 15.9.2. Cell Source
  - 15.9.3. Cell Type
  - 15.9.4. Technology
  - 15.9.5. Therapeutic Application
  - 15.9.6. Treatment Approach
  - 15.9.7. End-Use
- 15.10. Malaysia Stem Cell Therapy Market
  - 15.10.1. Country Segmental Analysis
  - 15.10.2. Cell Source
  - 15.10.3. Cell Type
  - 15.10.4. Technology
  - 15.10.5. Therapeutic Application
  - 15.10.6. Treatment Approach
  - 15.10.7. End-Use
- 15.11. Thailand Stem Cell Therapy Market
  - 15.11.1. Country Segmental Analysis
  - 15.11.2. Cell Source
  - 15.11.3. Cell Type
  - 15.11.4. Technology
  - 15.11.5. Therapeutic Application
  - 15.11.6. Treatment Approach
  - 15.11.7. End-Use
- 15.12. Vietnam Stem Cell Therapy Market
  - 15.12.1. Country Segmental Analysis
  - 15.12.2. Cell Source
  - 15.12.3. Cell Type
  - 15.12.4. Technology
  - 15.12.5. Therapeutic Application
  - 15.12.6. Treatment Approach
  - 15.12.7. End-Use
- 15.13. Rest of Asia Pacific Stem Cell Therapy Market
  - 15.13.1. Country Segmental Analysis
  - 15.13.2. Cell Source
  - 15.13.3. Cell Type
  - 15.13.4. Technology
  - 15.13.5. Therapeutic Application
  - 15.13.6. Treatment Approach
  - 15.13.7. End-Use
16. Middle East Stem Cell Therapy Market Analysis
- 16.1. Key Segment Analysis
- 16.2. Regional Snapshot
- 16.3. Middle East Stem Cell Therapy Market Size (Value - US$ Bn), Analysis, and Forecasts, 2021-2035
  - 16.3.1. Cell Source
  - 16.3.2. Cell Type
  - 16.3.3. Technology
  - 16.3.4. Therapeutic Application
  - 16.3.5. Treatment Approach
  - 16.3.6. End-Use
  - 16.3.7. Country
    - 16.3.7.1. Turkey
    - 16.3.7.2. UAE
    - 16.3.7.3. Saudi Arabia
    - 16.3.7.4. Israel
    - 16.3.7.5. Rest of Middle East
- 16.4. Turkey Stem Cell Therapy Market
  - 16.4.1. Country Segmental Analysis
  - 16.4.2. Cell Source
  - 16.4.3. Cell Type
  - 16.4.4. Technology
  - 16.4.5. Therapeutic Application
  - 16.4.6. Treatment Approach
  - 16.4.7. End-Use
- 16.5. UAE Stem Cell Therapy Market
  - 16.5.1. Country Segmental Analysis
  - 16.5.2. Cell Source
  - 16.5.3. Cell Type
  - 16.5.4. Technology
  - 16.5.5. Therapeutic Application
  - 16.5.6. Treatment Approach
  - 16.5.7. End-Use
- 16.6. Saudi Arabia Stem Cell Therapy Market
  - 16.6.1. Country Segmental Analysis
  - 16.6.2. Cell Source
  - 16.6.3. Cell Type
  - 16.6.4. Technology
  - 16.6.5. Therapeutic Application
  - 16.6.6. Treatment Approach
  - 16.6.7. End-Use
- 16.7. Israel Stem Cell Therapy Market
  - 16.7.1. Country Segmental Analysis
  - 16.7.2. Cell Source
  - 16.7.3. Cell Type
  - 16.7.4. Technology
  - 16.7.5. Therapeutic Application
  - 16.7.6. Treatment Approach
  - 16.7.7. End-Use
- 16.8. Rest of Middle East Stem Cell Therapy Market
  - 16.8.1. Country Segmental Analysis
  - 16.8.2. Cell Source
  - 16.8.3. Cell Type
  - 16.8.4. Technology
  - 16.8.5. Therapeutic Application
  - 16.8.6. Treatment Approach
  - 16.8.7. End-Use
17. Africa Stem Cell Therapy Market Analysis
- 17.1. Key Segment Analysis
- 17.2. Regional Snapshot
- 17.3. Africa Stem Cell Therapy Market Size (Value - US$ Bn), Analysis, and Forecasts, 2021-2035
  - 17.3.1. Cell Source
  - 17.3.2. Cell Type
  - 17.3.3. Technology
  - 17.3.4. Therapeutic Application
  - 17.3.5. Treatment Approach
  - 17.3.6. End-Use
  - 17.3.7. Country
    - 17.3.7.1. South Africa
    - 17.3.7.2. Egypt
    - 17.3.7.3. Nigeria
    - 17.3.7.4. Algeria
    - 17.3.7.5. Rest of Africa
- 17.4. South Africa Stem Cell Therapy Market
  - 17.4.1. Country Segmental Analysis
  - 17.4.2. Cell Source
  - 17.4.3. Cell Type
  - 17.4.4. Technology
  - 17.4.5. Therapeutic Application
  - 17.4.6. Treatment Approach
  - 17.4.7. End-Use
- 17.5. Egypt Stem Cell Therapy Market
  - 17.5.1. Country Segmental Analysis
  - 17.5.2. Cell Source
  - 17.5.3. Cell Type
  - 17.5.4. Technology
  - 17.5.5. Therapeutic Application
  - 17.5.6. Treatment Approach
  - 17.5.7. End-Use
- 17.6. Nigeria Stem Cell Therapy Market
  - 17.6.1. Country Segmental Analysis
  - 17.6.2. Cell Source
  - 17.6.3. Cell Type
  - 17.6.4. Technology
  - 17.6.5. Therapeutic Application
  - 17.6.6. Treatment Approach
  - 17.6.7. End-Use
- 17.7. Algeria Stem Cell Therapy Market
  - 17.7.1. Country Segmental Analysis
  - 17.7.2. Cell Source
  - 17.7.3. Cell Type
  - 17.7.4. Technology
  - 17.7.5. Therapeutic Application
  - 17.7.6. Treatment Approach
  - 17.7.7. End-Use
- 17.8. Rest of Africa Stem Cell Therapy Market
  - 17.8.1. Country Segmental Analysis
  - 17.8.2. Cell Source
  - 17.8.3. Cell Type
  - 17.8.4. Technology
  - 17.8.5. Therapeutic Application
  - 17.8.6. Treatment Approach
  - 17.8.7. End-Use
18. South America Stem Cell Therapy Market Analysis
- 18.1. Key Segment Analysis
- 18.2. Regional Snapshot
- 18.3. South America Stem Cell Therapy Market Size (Value - US$ Bn), Analysis, and Forecasts, 2021-2035
  - 18.3.1. Cell Source
  - 18.3.2. Cell Type
  - 18.3.3. Technology
  - 18.3.4. Therapeutic Application
  - 18.3.5. Treatment Approach
  - 18.3.6. End-Use
  - 18.3.7. Country
    - 18.3.7.1. Brazil
    - 18.3.7.2. Argentina
    - 18.3.7.3. Rest of South America
- 18.4. Brazil Stem Cell Therapy Market
  - 18.4.1. Country Segmental Analysis
  - 18.4.2. Cell Source
  - 18.4.3. Cell Type
  - 18.4.4. Technology
  - 18.4.5. Therapeutic Application
  - 18.4.6. Treatment Approach
  - 18.4.7. End-Use
- 18.5. Argentina Stem Cell Therapy Market
  - 18.5.1. Country Segmental Analysis
  - 18.5.2. Cell Source
  - 18.5.3. Cell Type
  - 18.5.4. Technology
  - 18.5.5. Therapeutic Application
  - 18.5.6. Treatment Approach
  - 18.5.7. End-Use
- 18.6. Rest of South America Stem Cell Therapy Market
  - 18.6.1. Country Segmental Analysis
  - 18.6.2. Cell Source
  - 18.6.3. Cell Type
  - 18.6.4. Technology
  - 18.6.5. Therapeutic Application
  - 18.6.6. Treatment Approach
  - 18.6.7. End-Use
19. Key Players/ Company Profile
- 19.1. Anterogen Co., Ltd.
  - 19.1.1. Company Details/ Overview
  - 19.1.2. Company Financials
  - 19.1.3. Key Customers and Competitors
  - 19.1.4. Business/ Industry Portfolio
  - 19.1.5. Product Portfolio/ Specification Details
  - 19.1.6. Pricing Data
  - 19.1.7. Strategic Overview
  - 19.1.8. Recent Developments
- 19.2. Astellas Pharma Inc.
- 19.3. Athersys Inc.
- 19.4. Brainstorm Cell Therapeutics
- 19.5. Caladrius Biosciences Inc.
- 19.6. CBR Systems Inc.
- 19.7. Cellular Engineering Technologies Inc.
- 19.8. CORESTEM Inc.
- 19.9. Cynata Therapeutics Limited
- 19.10. Fate Therapeutics Inc.
- 19.11. Holostem Terapie Avanzate S.r.l.
- 19.12. JCR Pharmaceuticals Co., Ltd.
- 19.13. MEDIPOST Co., Ltd.
- 19.14. Mesoblast Ltd
- 19.15. NuVasive Inc.
- 19.16. Osiris Therapeutics (Smith & Nephew)
- 19.17. Pharmicell Co., Ltd.
- 19.18. Pluristem Therapeutics Inc.
- 19.19. Stempeutics Research Pvt Ltd
- 19.20. Takeda Pharmaceutical Company Limited
- 19.21. Vericel Corporation
- 19.22. ViaCyte Inc.
- 19.23. Other Key Players

Note* - This is just tentative list of players. While providing the report, we will cover more number of players based on their revenue and share for each geography

Get PDF

PRICING DETAILS

Single-User Upto 2 Users - [PDF + Excel Only]

USD 4150

Multi-User Upto 10 Users - [PDF + Excel + PPT]

USD 5950

Enterprise-User Company-wide - [Report Pack + Benchmark + 6M Update]

USD 7750

Related Report

Discount On Multiple Reports

Where did We Help Most?

Custom Market Research Services

We will customise the research for you, in case the report listed above does not meet your requirements.

Get 10% Free Customisation